[ET Net News Agency, 20 August 2021] HANSOH PHARMA (03692) fell 5.04% to HK$24.5.
It hits an intra-day low of HK$24.5, hitting a 52-week low, and an intra-day high of
HK$25.9. The total shares traded was 2.15 million, with a value of HK$54.07m. The active
buy/sell ratio is 60:40, with net buying turnover of HK$10.26m. DAIWA CAPITAL MARKETS HK
accounts for greatest net responsive buying turnover of HK$3.24m, with volume weighted
average price of HK$25.027. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive
selling turnover of HK$5.1m, with volume weighted average price of HK$25.06. The stock has
fallen a combined 5.41% over the past 2 consecutive trading days.
The Hang Seng Index now fell 605 points, or 2.39% to 24,711; the Hang Seng China
Enterprises Index now fell 220 points, or 2.47% to 8,695; the Hang Seng TECH Index now
fell 216 points, or 3.58% to 5,827; with an overall turnover of HK$124.18b.
The SSE Composite Index now fell 64 points, or 1.87% to 3,400, with an overall turnover
of RMB372.77b.
The SZSE Component Index now fell 357 points, or 2.47% to 14,129, with an overall
turnover of RMB240.56b.

Basic Information
-------------------------------------------
Nominal 24.500 % Chg -5.04%
High 25.900 Low 24.500
Shares Tr 2.15m Turnover 54.07m
10-D SMA 26.135 %H.V 64.935
20-D SMA 26.908 VWAP 25.166
50-D SMA 30.206 RSI14 32.991
-------------------------------------------
Status: Hitting a 52-week low, active buy/sell ratio is 60:40, with net buying turnover
of HK$10.26m, falling a combined 5.41% over the past 2 consecutive trading days

Table: Performance of stocks in the same sector or of relevance

Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
HANSOH PHARMA (03692) 24.50 -5.04
SIHUAN PHARM (00460) 2.09 -7.11
CMS (00867) 16.12 -6.50
CSPC PHARMA (01093) 10.16 -6.79
SINO BIOPHARM (01177) 6.33 -4.38
3SBIO (01530) 6.82 -7.08
LUYE PHARMA (02186) 3.78 -3.08
FOSUN PHARMA (02196) 48.70 -8.89
WUXI APPTEC (02359) 135.20 -6.82
PHARMARON (03759) 148.80 -5.10
-------------------------------------------------
(ed)